Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Qilu Pharmaceutical
Biotech
Takeda inks $1.7B AI discovery deal with Iambic Therapeutics
The project aims to advance certain Takeda small molecules, with the work starting in the oncology, gastrointestinal and inflammation treatment areas.
Will Maddox
Feb 9, 2026 8:00am
Lisata reclaims China rights to solid tumor candidate from Qilu
Jan 27, 2026 10:12am
Qilu inks $120M, AI-enabled cardiometabolic pact with Insilico
Jan 27, 2026 5:20am
Arbutus regains China rights to potential hep B cure from Qilu
Jun 25, 2025 9:15am
Qilu pays $38M upfront for rights to Minghui's ADC
May 9, 2025 7:20am
